Literature DB >> 8278195

Glasgow Acuity Cards: a new test for the measurement of letter acuity in children.

P V McGraw1, B Winn.   

Abstract

Problems with design and format of the traditional Snellen chart have led to the development of alternative charts for the measurement of visual acuity in adults. However, advances in chart design for the measurement of visual acuity in pre-school children have not paralleled those used in adult test charts. Visual acuity can be measured in infants and very young children using behavioural and electrophysiological techniques but clinical measurement of letter acuity tends to commence when the child is old enough to interact and co-operate with the examiner. Charts which are commercially available in the UK for measuring letter acuity in pre-school children (3-5 years old) either use single optotypes or are derivatives of the Snellen format. There is a need for a test of letter acuity for use with this young age group which is accurate, reliable and based upon sound and established design principles. Glasgow Acuity Cards have been designed to include features that should allow change in letter acuity to be detected in pre-school children, especially those undergoing vision therapy training. The test is performed at 3 m and incorporates several design features which have been used previously in adult charts but are new to childrens' test charts. These include: linear progression of letter sizes using a log scale; letters of approximately equal legibility; equal number of letters per line; control of contour interaction; screening cards to determine initial level of acuity. The test is quick and easy to perform and should provide a means of detecting change in letter acuity, with increased confidence.

Entities:  

Mesh:

Year:  1993        PMID: 8278195     DOI: 10.1111/j.1475-1313.1993.tb00499.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  33 in total

1.  Use of Lea symbols in young children.

Authors:  M X Repka
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

2.  Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?

Authors:  M Cleary
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

3.  Screening for amblyopia: a comparison of paediatric letter tests.

Authors:  A J Simmers; L S Gray; K Spowart
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

4.  Visual acuity measurements in a national sample of British elderly people.

Authors:  J C van der Pols; C J Bates; P V McGraw; J R Thompson; M Reacher; A Prentice; S Finch
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

5.  The pattern of learned visual improvements in adult amblyopia.

Authors:  Andrew T Astle; Ben S Webb; Paul V McGraw
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-14       Impact factor: 4.799

6.  Improving vision: neural compensation for optical defocus.

Authors:  M Mon-Williams; J R Tresilian; N C Strang; P Kochhar; J P Wann
Journal:  Proc Biol Sci       Date:  1998-01-07       Impact factor: 5.349

7.  Brief Report: Vision in Children with Autism Spectrum Disorder: What Should Clinicians Expect?

Authors:  Pamela M Anketell; Kathryn J Saunders; Stephen M Gallagher; Clare Bailey; Julie-Anne Little
Journal:  J Autism Dev Disord       Date:  2015-09

8.  Screening older people for impaired vision in primary care: cluster randomised trial.

Authors:  Liam Smeeth; Astrid E Fletcher; Smita Hanciles; Jennifer Evans; Richard Wormald
Journal:  BMJ       Date:  2003-11-01

9.  Causes of visual impairment in people aged 75 years and older in Britain: an add-on study to the MRC Trial of Assessment and Management of Older People in the Community.

Authors:  J R Evans; A E Fletcher; R P L Wormald
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

10.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.